Changes of Colorectal Cancer Diagnostics and Hospitalizations during First Wave of COVID-19 Pandemic in Lithuania
Case studies
Dignė Jurkevičiūtė
Faculty of Medicine, Vilnius University, Vilnius, Lithuania
https://orcid.org/0000-0003-4358-1522
Sandra Mauravičiūtė
Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Audrius Dulskas
Faculty of Medicine, Vilnius University, Vilnius, Lithuania; National Cancer Institute, Vilnius, Lithuania
https://orcid.org/0000-0003-3692-8962
Inga Kildušienė
National Cancer Institute, Vilnius, Lithuania
Eugenijus Stratilatovas
National Cancer Institute, Vilnius, Lithuania
Sonata Jarmalaitė
National Cancer Institute, Vilnius, Lithuania
Published 2023-02-23
https://doi.org/10.15388/Amed.2023.30.1.4
PDF
HTML

Keywords

COVID-19 pandemic
colorectal cancer
colorectal cancer screening
short-term results

How to Cite

1.
Jurkevičiūtė D, Mauravičiūtė S, Dulskas A, Kildušienė I, Stratilatovas E, Jarmalaitė S. Changes of Colorectal Cancer Diagnostics and Hospitalizations during First Wave of COVID-19 Pandemic in Lithuania. AML [Internet]. 2023 Feb. 23 [cited 2024 Apr. 28];30(1):4. Available from: https://www.journals.vu.lt/AML/article/view/29497

Abstract

Purpose: Our aim was to see the possible effect of the first COVID pandemic wave in Lithuania on colorectal cancer (CRC) preventive, diagnostic and treatment procedures.
Methods: A retrospective analysis was performed using the database of the National Cancer Institute, Lithuania. We have divided patients into two groups: group 1 – patients treated during the nonpandemic period (2019 January 1 to 2019 July 31) and group 2 – the pandemic period (2020 January 1 to 2020 July 31). We analyzed numbers of screening, therapeutic colonoscopies performed, and treated patients for CRC during two periods.
Results: In general, 1318 lower gastrointestinal endoscopic procedures were performed in the first group and 862 procedures in the second group, which was 34.6% less compared to the first group. The first group included 672 (51%) colonoscopies, 172 (13%) day surgeries and 474 (36%) CRC screening programmes. In group 2, 456 (34.6%) less patients underwent CRC diagnostics and treatment: 141 (21%) less colonoscopies, 93 (54%) less day surgeries, 222 (47%) less CRC screening programmes, and 26 (13%) less patients were hospitalized for surgical treatment (196 vs 170).
Conclusion: Our study reveals worrying changes in the timely access to diagnostic procedures during the COVID-19 pandemic that possibly provoked rise in cases with the advanced stage CRC. However, despite numerical difference between groups existed, the difference between groups do not reach statistical significant level.

PDF
HTML

Downloads

Download data is not yet available.

Most read articles by the same author(s)